Accreditation Statistics

As of August 1, 2022

Cellular Therapy Entities

  • Accredited: 250
  • Applicants: 25

Cord Blood Banks

  • Accredited: 56
  • Applicants: 7

Congratulations to the following program for achieving initial FACT accreditation: King Abdulaziz Medical City - Riyadh, Saudi Arabia (adult and pediatric allogeneic and autologous hematopoietic progenitor cellular therapy; marrow and peripheral blood cellular therapy product collection; cellular therapy product processing with minimal manipulation). A complete list of accredited organizations can be found at

Update for HRSA-contracted Cord Blood Banks

Posted in :: 2020 Volume 4 :: Thursday, June 18th, 2020

FACT is a designated accrediting body for the Health Resources and Services Administration (HRSA)-contracted Cord Blood Banks participating in the National Cord Blood Inventory (NCBI).  These cord blood banks have been required to maintain FACT accreditation and also to meet HRSA-specific criteria that were detailed for FACT inspectors on Part H of the Compliance Checklist.

In April 2020, HRSA determined that the HRSA-specific criteria were not useful in monitoring the NCBI contracts and that these criteria had become obsolete. Therefore, these HRSA-specific criteria have been deleted.  Part H of the FACT Compliance Checklist has been archived, and FACT inspectors will no longer be required to complete additional information for HRSA-contracted cord blood banks. All accredited cord blood banks will be assessed similarly against the current edition of NetCord-FACT International Standards for Cord Blood Collection, Banking, and Release for Administration.